Pathology Doctors in Columbia, MD Accepting Medicare

8 Pathology doctors found. Showing 1 - 8

Rennae Anderson, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-940-7890

Dr. Richard Charles Marsella, M.D.,PH.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 5450 Knoll North Dr, Columbia, MD 21045 Phone: 443-618-6596

Jeffrey Pinco, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln Dept Of, Columbia, MD 21044 Phone: 410-740-7861

Dr. Henry Harrison Bell Jr., M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7852

Anita Godra, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 10320 Swift Stream Pl, #405, Columbia, MD 21044 Phone: 410-423-9481

Dr. Stephanie Michelle Richards, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7861

Lola Hoover, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7890

Stanley John Podlasek, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7852

News Archive

Monoclonal antibody inhibits tumor growth in angiosarcoma and breast cancer

A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study.

Stereotactic radiosurgery effectively controls pain in patients with cancer

Stereotactic radiosurgery (SRS), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors, effectively controls pain in patients with cancer that has spread to the spine, according to researchers from UPCI.

New technology offers hope to millions suffering from tinnitus

As many as 50 million Americans suffer from tinnitus, a debilitating health condition commonly known as "ringing in the ears." Musicians, factory workers, military veterans and many others endure its effects, including problems with concentration, sleep, anxiety and depression.

Medtronic named 2010 MDEA winner for excellence in medical device design

Medtronic announced today that the company was named a 2010 Medical Device Excellence Award winner for excellence in medical device design for its Hydrodebrider System, manufactured by the company's Ear Nose and Throat business unit.

Read more Medical News

› Verified 9 days ago